View by type:
Articles (4214)
How Gavi, UNICEF and WHO supported Timor-Leste’s successful COVID-19 response strategy
Timor Leste has kept COVID-19 infections to a minimum, and thanks to effective collaboration has managed to successfully reverse the initial declines seen in immunisation coverage and health service delivery.
Timor-Leste’s Director-General of Health Services for the Ministry of Health discusses the unique challenges of tackling COVID-19 in Timor-Leste and how have they been addressed.
Strengthening supply chains: a long-term investment
The Vaccine Alliance has been working hard in recent years to build greater resilience in supply chains, an effort that is starting to show results.
Why we need a “portfolio approach” to COVID-19 vaccine development
Most vaccine candidates in early development fail: this is the stark reality of vaccine development.
Children who get zero vaccines deserve 100% of our attention
Over 50% more children were immunised in Gavi countries in 2019 than in 2000, yet 10.6 million children continue to miss out entirely on basic vaccinations. Here’s why reaching these children and setting them on the pathway to full immunisation…
Once we have effective Covid-19 treatments, it shouldn’t only be the rich who benefit
We need a range of treatments to make Covid-19 preventable and treatable. Jeremy Farrar describes recent progress made by research and why more investment is needed.
Boosting demand for immunisation
Building and maintaining demand for immunisation is an integral part of Gavi’s work to increase coverage and equity. Here’s an insight into how we have achieved this.
Brazil city ‘might have reached herd immunity'
Herd immunity threshold may have been reached in Amazonas capital, Manaus, but experts warn that herd immunity is not the end of the pandemic.
Why some people might be immune to certain COVID-19 vaccines
Vaccines based on the common cold virus are at the forefront of the COVID-19 vaccine race, but they may be less effective in people who have previously been infected by these common pathogens. So how could we overcome this challenge?
Gavi receives 2020 Princess of Asturias Award for International Cooperation
Gavi recognised for facilitating universal access to vaccines to reduce the impact of infectious diseases and contributing to the protection of half of the global child population through vaccination.
How innovative finance can fight deadly diseases
One of the vital components to Gavi’s capital structure is the International Finance Facility for Immunisation (IFFIm). A powerful and award-winning financial tool launched in 2006, IFFIm issues Vaccine Bonds on the capital markets against long-…
Why handwashing with soap is the most effective way to stop viruses
Global Handwashing Day and the ongoing spread of COVID-19 is a timely reminder about the importance of handwashing with soap as an effective and affordable way to stay healthy.